Study: Generic biologics not much cheaper

May 3, 2007

A U.S. study has determined generic versions of a class of medicines called "biologics" would not be significantly cheaper than brand-name drugs.

Biologics are drugs, vaccines and other medicines produced by living cells in controlled circumstances, but there is no established process for the review and approval of generic versions of biologic products, such as insulin.

"Congress and the (U.S. Food and Drug Administration) are currently addressing this issue and developing a process for the oversight of generic biologics, partially in hopes of generating significant cost savings for consumers and insurers," said Duke University Professor Kevin Schulman. "However, our research indicates that any savings to be expected from the addition of generic biologics to the marketplace will be significantly less than the savings generally available from generic pharmaceuticals."

The study, which also included Professors David Ridley and Henry Grabowski as authors, is to be published in the journal Managerial and Decision Economics.

Copyright 2007 by United Press International

Explore further: 'Generic' biologic drugs appear comparable to brand-name counterparts

Related Stories

'Generic' biologic drugs appear comparable to brand-name counterparts

August 1, 2016
Generic forms of a biologic drug used to treat rheumatoid arthritis, inflammatory bowel disease and psoriasis appear to be as safe and effective as their brand-name counterparts, a new Johns Hopkins Bloomberg School of Public ...

Biosimilar drugs could create billions in health care savings, study finds

November 3, 2014
Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, ...

After generics it's the turn of biosimilars, a budding market

September 9, 2014
What can be regarded as pioneering research worldwide has been conducted by the UPV/EHU-University of the Basque Country within the European regulatory framework for biosimiliar drugs.

How newest class of drugs could save billions of dollars

March 31, 2015
Clad in white lab coats, blue gloves and safety goggles, scientists are buzzing around a lab at Hospira in this suburb north of Chicago.

Generic medications boost adherence to breast cancer therapy

October 28, 2014
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor–positive tumors, about one-half of patients fail to take their medications as directed. A study by ...

Math can save Tylenol overdose patients

February 27, 2012
University of Utah mathematicians developed a set of calculus equations to make it easier for doctors to save Tylenol overdose patients by quickly estimating how much painkiller they took, when they consumed it and whether ...

Recommended for you

Glucocorticoids offer long-term benefits for patients with Duchenne muscular dystrophy

November 22, 2017
Glucocorticoids, a class of steroid hormone medications often prescribed to patients with Duchenne muscular dystrophy (DMD), offer long-term benefits for this disease, including longer preservation of muscle strength and ...

Baby-boomers and millennials more afflicted by the opioid epidemic

November 21, 2017
Baby-boomers, those born between 1947 and 1964, experienced an excess risk of prescription opioid overdose death and heroin overdose death, according to latest research at Columbia University's Mailman School of Public Health. ...

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.